A systematic review and meta‐analysis encompassing 15 clinical trials has concluded that pharmacogenomic‐guided depression treatment results in a small improvement in antidepressant efficacy relative to treatment as usual. There was no difference in treatment discontinuation rates between pharmacogenomic‐guided and conventional treatment.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: